Illumina Ventures is an independently managed venture fund with a formal strategic partnership to Illumina that provides majority capital and access to internal genomics expertise, positioning it as an external VC with quasi-insider access to the world's leading sequencing platform provider. The fund operates Illumina Ventures Labs, an in-house company creation engine that combines capital with fully equipped genomics labs and sequencing capacity, using a hybrid cash plus in-kind investment model to take concepts from formation through Series A within the same platform.